BMY
$55.94
Revenue | $12222Mn |
Net Profits | $2201Mn |
Net Profit Margins | 18.01% |
Bristol-myers Squibb Co.’s revenue jumped 2.77% since last year same period to $12222Mn in the Q3 2025. On a quarterly growth basis, Bristol-myers Squibb Co. has generated -0.38% fall in its revenue since last 3-months.
Bristol-myers Squibb Co.’s net profit jumped 81.75% since last year same period to $2201Mn in the Q3 2025. On a quarterly growth basis, Bristol-myers Squibb Co. has generated 68.02% jump in its net profits since last 3-months.
Bristol-myers Squibb Co.’s net profit margin jumped 76.84% since last year same period to 18.01% in the Q3 2025. On a quarterly growth basis, Bristol-myers Squibb Co. has generated 68.66% jump in its net profit margins since last 3-months.
EPS Estimate Current Quarter | 1.44 |
EPS Estimate Current Year | 1.44 |
Bristol-myers Squibb Co.’s earning per share (EPS) estimates for the current quarter stand at 1.44 - a -11.66% fall from last quarter’s estimates.
Bristol-myers Squibb Co.’s earning per share (EPS) estimates for the current year stand at 1.44.
Earning Per Share (EPS) | 0 |
Dividend Per Share (DPS) | 0.63 |
Bristol-myers Squibb Co.’s earning per share (EPS) fell -100% since last year same period to 0 in the Q1 2026. This indicates that the Bristol-myers Squibb Co. has generated -100% annual rate of fall in its earning per share (EPS) in the last 4 quarters.
Bristol-myers Squibb Co. declared 0.63 dividend per share during the earnings announcement for Q1 2026.
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2026-04-30 | 1.44 | 0 | -100% |